The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

These findings align closely with external research as well. For example, Foundry's 2023 ABM and Intent Benchmarking Study ...

Solsten launched Elaris, an empathic intelligence platform that helps marketers understand audiences through real psychological data rather ...

Starton Holdings plans $40M IPO for cancer drug delivery innovations, but weak IP and limited backing make this a potentially ...

ZoomInfo reports that 95% of enterprise AI projects fail to deliver ROI due to inadequate data infrastructure. Successful ...

Geoff Steward and Rebecca Newman of Addleshaw Goddard explain how they secured victory in a rare ‘genericide’ case and why ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more on LLY stock here.

AI has become a central part of how marketing teams work, but the results often fall short. Models can generate content at scale and summarize information in seconds, yet the outputs are not always ...

The National Security Strategy, which presidents usually release once each term, offers a formal statement of U.S. global ...

The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...